Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Muscles can make their own androgens, which may help muscle growth.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

A new method accurately measures nine specific hormones in human blood.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Compounds from Jatropha cordata bark have significant anti-inflammatory effects and could help with hair loss.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The mouse models are effective for testing new hair loss treatments.

Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose can help treat hair loss by reducing certain hormones and promoting hair growth.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.